File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Conference Paper: HBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcome
  • Basic View
  • Metadata View
  • XML View
TitleHBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcome
 
AuthorsSeto, WK
Lai, CL
Fung, J
Wong, D
Yuen, JCH
Hung, IFN
Yuen, MF
 
KeywordsMedical sciences
Gastroenterology
 
Issue Date2010
 
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
 
CitationThe 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456 [How to Cite?]
DOI: http://dx.doi.org/10.1002/hep.23990
 
AbstractBACKGROUND: The significance of serum week 12 HBV DNA in predicting long-term outcomes of chronic hepatitis B (CHB) patients on telbivudine is not yet defined. Methods: We determined the cumulative rates of HBeAg …
 
ISSN0270-9139
2012 Impact Factor: 12.003
2012 SCImago Journal Rankings: 4.260
 
DOIhttp://dx.doi.org/10.1002/hep.23990
 
DC FieldValue
dc.contributor.authorSeto, WK
 
dc.contributor.authorLai, CL
 
dc.contributor.authorFung, J
 
dc.contributor.authorWong, D
 
dc.contributor.authorYuen, JCH
 
dc.contributor.authorHung, IFN
 
dc.contributor.authorYuen, MF
 
dc.date.accessioned2011-08-26T14:33:10Z
 
dc.date.available2011-08-26T14:33:10Z
 
dc.date.issued2010
 
dc.description.abstractBACKGROUND: The significance of serum week 12 HBV DNA in predicting long-term outcomes of chronic hepatitis B (CHB) patients on telbivudine is not yet defined. Methods: We determined the cumulative rates of HBeAg …
 
dc.description.naturelink_to_OA_fulltext
 
dc.description.otherThe 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456
 
dc.identifier.citationThe 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456 [How to Cite?]
DOI: http://dx.doi.org/10.1002/hep.23990
 
dc.identifier.doihttp://dx.doi.org/10.1002/hep.23990
 
dc.identifier.epage547A
 
dc.identifier.hkuros190373
 
dc.identifier.issn0270-9139
2012 Impact Factor: 12.003
2012 SCImago Journal Rankings: 4.260
 
dc.identifier.issuesuppl. S1
 
dc.identifier.openurl
 
dc.identifier.spage547A
 
dc.identifier.urihttp://hdl.handle.net/10722/137774
 
dc.identifier.volume52
 
dc.languageeng
 
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
 
dc.relation.ispartofHepatology
 
dc.rightsHepatology. Copyright © John Wiley & Sons, Inc.
 
dc.subjectMedical sciences
 
dc.subjectGastroenterology
 
dc.titleHBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcome
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Seto, WK</contributor.author>
<contributor.author>Lai, CL</contributor.author>
<contributor.author>Fung, J</contributor.author>
<contributor.author>Wong, D</contributor.author>
<contributor.author>Yuen, JCH</contributor.author>
<contributor.author>Hung, IFN</contributor.author>
<contributor.author>Yuen, MF</contributor.author>
<date.accessioned>2011-08-26T14:33:10Z</date.accessioned>
<date.available>2011-08-26T14:33:10Z</date.available>
<date.issued>2010</date.issued>
<identifier.citation>The 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456</identifier.citation>
<identifier.issn>0270-9139</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/137774</identifier.uri>
<description.abstract>BACKGROUND: The significance of serum week 12 HBV DNA in predicting long-term outcomes of chronic hepatitis B (CHB) patients on telbivudine is not yet defined. Methods: We determined the cumulative rates of HBeAg &#8230;</description.abstract>
<language>eng</language>
<publisher>John Wiley &amp; Sons, Inc. The Journal&apos;s web site is located at http://www.hepatology.org/</publisher>
<relation.ispartof>Hepatology</relation.ispartof>
<rights>Hepatology. Copyright &#169; John Wiley &amp; Sons, Inc.</rights>
<subject>Medical sciences</subject>
<subject>Gastroenterology</subject>
<title>HBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcome</title>
<type>Conference_Paper</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0270-9139&amp;volume=52&amp;issue=Suppl. S1&amp;spage=547A, abstract no. 456&amp;epage=&amp;date=2010&amp;atitle=HBV+DNA+levels+after+12+weeks+of+telbivudine+treatment+in+chronic+hepatitis+B+predicts+long-term+outcome</identifier.openurl>
<description.nature>link_to_OA_fulltext</description.nature>
<identifier.doi>10.1002/hep.23990</identifier.doi>
<identifier.hkuros>190373</identifier.hkuros>
<identifier.volume>52</identifier.volume>
<identifier.issue>suppl. S1</identifier.issue>
<identifier.spage>547A</identifier.spage>
<identifier.epage>547A</identifier.epage>
<description.other>The 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010), Vienna, Austria, 14-18 April 2010. In Hepatology, 2010, v. 52 suppl. S1, p. 547A, abstract no. 456</description.other>
<bitstream.url>http://hub.hku.hk/bitstream/10722/137774/1/re01.htm</bitstream.url>
</item>